Seegene, Inc. (KOSDAQ:096530)
28,050
-100 (-0.36%)
Jun 12, 2026, 3:30 PM KST
Seegene Revenue
Seegene had revenue of 129.14B KRW in the quarter ending March 31, 2026, with 11.33% growth. This brings the company's revenue in the last twelve months to 487.37B, up 10.69% year-over-year. In the year 2025, Seegene had annual revenue of 474.23B with 14.48% growth.
Revenue (ttm)
487.37B
Revenue Growth
+10.69%
P/S Ratio
2.65
Revenue / Employee
2.26B
Employees
216
Market Cap
1.29T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 474.23B | 59.98B | 14.48% |
| Dec 31, 2024 | 414.25B | 46.88B | 12.76% |
| Dec 31, 2023 | 367.38B | -486.19B | -56.96% |
| Dec 31, 2022 | 853.56B | -517.27B | -37.73% |
| Dec 31, 2021 | 1.37T | 245.62B | 21.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| i-SENS | 314.31B |
| InBody Co.,Ltd | 246.81B |
| WON TECH | 159.67B |
| DRTECH | 122.78B |
| Osang Healthcare Co.,Ltd | 119.38B |
| L&C BIO Co.,LTD | 98.10B |
| Bio Plus | 94.42B |
| SEERS | 76.63B |